IONS Covered Call Strategy
IONS (Ionis Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adult patients; and WAYLIVRA, which addresses familial chylomicronemia syndrome and familial partial lipodystrophy. Ionis also maintains a robust pipeline, with several drug candidates currently in Phase 3 clinical trials. These include Eplontersen, a monthly self-administered subcutaneous injection designed for all forms of TTR amyloidosis; Olezarsen, intended for individuals with severe hypertriglyceridemia (SHTG); Donidalorsen, for patients suffering from hereditary angioedema; ION363, aimed at amyotrophic lateral sclerosis (ALS); Pelacarsen, developed for those with established cardiovascular disease and elevated lipoprotein(a); and Tofersen, which works by inhibiting the production of superoxide dismutase 1. Beyond these late-stage assets, the company is actively researching treatments for metabolic, infectious, renal, and ophthalmic diseases, as well as various types of cancer. The firm engages in significant collaborations, notably a strategic partnership with Biogen Inc.
IONS (Ionis Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $7.42B, a beta of 0.42 versus the broader market, a 52-week range of 43.01-86.74, average daily share volume of 3.2M, a public-listing history dating back to 1991, approximately 1K full-time employees. These structural characteristics shape how IONS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.42 indicates IONS has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on IONS?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
IONS snapshot
As of September 30, 2026, spot at $45.39, ATM IV 45.30%, IV rank 9.44%, expected move 12.99%. The covered call on IONS below is built from the September 30, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 16-day expiry.
Why this covered call structure on IONS specifically: IONS IV at 45.30% is on the cheap side of its 1-year range, which means a premium-selling IONS covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 12.99% (roughly $5.89 on the underlying). The 16-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IONS expiries trade a higher absolute premium for lower per-day decay. Position sizing on IONS should anchor to the underlying notional of $45.39 per share and to the trader's directional view on IONS stock.
IONS covered call setup
The IONS covered call below is built from the September 30, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IONS at $45.39 on that close, the first option leg uses a $47.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IONS chain at a 16-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IONS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $45.39 | long |
| Sell 1 | Call | $47.50 | $0.98 |
IONS covered call risk and reward
- Net Premium / Debit
- -$4,441.50
- Max Profit (per contract)
- $308.50
- Max Loss (per contract)
- -$4,440.50
- Breakeven(s)
- $44.42
- Risk / Reward Ratio
- 0.069
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
IONS covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on IONS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$4,440.50 |
| $10.04 | -77.9% | -$3,437.01 |
| $20.08 | -55.8% | -$2,433.53 |
| $30.11 | -33.7% | -$1,430.04 |
| $40.15 | -11.5% | -$426.55 |
| $50.18 | +10.6% | +$308.50 |
| $60.22 | +32.7% | +$308.50 |
| $70.25 | +54.8% | +$308.50 |
| $80.29 | +76.9% | +$308.50 |
| $90.32 | +99.0% | +$308.50 |
When traders use covered call on IONS
Covered calls on IONS are an income strategy run on existing IONS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
IONS thesis for this covered call
The market-implied 1-standard-deviation range for IONS extends from approximately $39.50 on the downside to $51.28 on the upside. A IONS covered call collects premium on an existing long IONS position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether IONS will breach that level within the expiration window. Current IONS IV rank near 9.44% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IONS at 45.30%. As a Healthcare name, IONS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IONS-specific events.
IONS covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IONS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IONS alongside the broader basket even when IONS-specific fundamentals are unchanged. Short-premium structures like a covered call on IONS carry tail risk when realized volatility exceeds the implied move; review historical IONS earnings reactions and macro stress periods before sizing. Always rebuild the position from current IONS chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on IONS?
- A covered call on IONS is the covered call strategy applied to IONS (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With IONS stock at $45.39 on the September 30, 2026 close, the strikes shown on this page are snapped to the nearest listed IONS chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are IONS covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the IONS covered call priced from the September 30, 2026 end-of-day chain at a 30-day expiry (ATM IV 45.30%), the computed maximum profit is $308.50 per contract and the computed maximum loss is -$4,440.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IONS covered call?
- The breakeven for the IONS covered call priced on this page is roughly $44.42 at expiration, derived from the September 30, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The IONS market-implied 1-standard-deviation expected move in the same options snapshot is approximately 12.99%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on IONS?
- Covered calls on IONS are an income strategy run on existing IONS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current IONS implied volatility affect this covered call?
- IONS ATM IV is at 45.30% with IV rank near 9.44%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.